McKesson Goodwill and Intangible Assets 2010-2025 | MCK
McKesson goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- McKesson goodwill and intangible assets for the quarter ending March 31, 2025 were $11.486B, a 6.18% decline year-over-year.
- McKesson goodwill and intangible assets for 2025 were $11.486B, a 6.18% decline from 2024.
- McKesson goodwill and intangible assets for 2024 were $12.242B, a 0.15% increase from 2023.
- McKesson goodwill and intangible assets for 2023 were $12.224B, a 6.2% increase from 2022.
McKesson Annual Goodwill and Intangible Assets
(Millions of US $) |
| 2025 |
$11,486 |
| 2024 |
$12,242 |
| 2023 |
$12,224 |
| 2022 |
$11,510 |
| 2021 |
$12,371 |
| 2020 |
$12,516 |
| 2019 |
$13,047 |
| 2018 |
$15,026 |
| 2017 |
$14,251 |
| 2016 |
$12,807 |
| 2015 |
$13,258 |
| 2014 |
$14,798 |
| 2013 |
$8,675 |
| 2012 |
$6,782 |
| 2011 |
$5,820 |
| 2010 |
$4,119 |
| 2009 |
$4,189 |
McKesson Quarterly Goodwill and Intangible Assets
(Millions of US $) |
| 2025-03-31 |
$11,486 |
| 2024-12-31 |
$11,513 |
| 2024-09-30 |
$11,660 |
| 2024-06-30 |
$12,163 |
| 2024-03-31 |
$12,242 |
| 2023-12-31 |
$12,070 |
| 2023-09-30 |
$12,076 |
| 2023-06-30 |
$12,192 |
| 2023-03-31 |
$12,224 |
| 2022-12-31 |
$12,207 |
| 2022-09-30 |
$11,111 |
| 2022-06-30 |
$11,344 |
| 2022-03-31 |
$11,510 |
| 2021-12-31 |
$11,592 |
| 2021-09-30 |
$11,858 |
| 2021-06-30 |
$12,317 |
| 2021-03-31 |
$12,371 |
| 2020-12-31 |
$12,491 |
| 2020-09-30 |
$12,444 |
| 2020-06-30 |
$12,509 |
| 2020-03-31 |
$12,516 |
| 2019-12-31 |
$12,820 |
| 2019-09-30 |
$12,897 |
| 2019-06-30 |
$13,041 |
| 2019-03-31 |
$13,047 |
| 2018-12-31 |
$14,439 |
| 2018-09-30 |
$14,755 |
| 2018-06-30 |
$14,843 |
| 2018-03-31 |
$15,026 |
| 2017-12-31 |
$15,922 |
| 2017-09-30 |
$15,938 |
| 2017-06-30 |
$15,988 |
| 2017-03-31 |
$14,251 |
| 2016-12-31 |
$14,195 |
| 2016-09-30 |
$12,754 |
| 2016-06-30 |
$14,270 |
| 2016-03-31 |
$12,807 |
| 2015-12-31 |
$12,804 |
| 2015-09-30 |
$13,065 |
| 2015-06-30 |
$13,375 |
| 2015-03-31 |
$13,258 |
| 2014-12-31 |
$13,820 |
| 2014-09-30 |
$14,194 |
| 2014-06-30 |
$14,821 |
| 2014-03-31 |
$14,798 |
| 2013-12-31 |
$8,366 |
| 2013-09-30 |
$8,473 |
| 2013-06-30 |
$8,458 |
| 2013-03-31 |
$8,675 |
| 2012-12-31 |
$7,109 |
| 2012-09-30 |
$6,827 |
| 2012-06-30 |
$6,703 |
| 2012-03-31 |
$6,782 |
| 2011-12-31 |
$5,838 |
| 2011-09-30 |
$5,870 |
| 2011-06-30 |
$5,853 |
| 2011-03-31 |
$5,820 |
| 2010-12-31 |
$5,917 |
| 2010-09-30 |
$4,049 |
| 2010-06-30 |
$4,044 |
| 2010-03-31 |
$4,119 |
| 2009-12-31 |
$4,139 |
| 2009-09-30 |
$4,165 |
| 2009-06-30 |
$4,179 |
| 2009-03-31 |
$4,189 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$88.766B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
